RT-PCR Combined with CT Examination in the Diagnosis and Prognosis Evaluation of COVID-19 Patients in Fangcang Hospital: A Case Series
- PMID: 33500623
- PMCID: PMC7826067
- DOI: 10.2147/JMDH.S293601
RT-PCR Combined with CT Examination in the Diagnosis and Prognosis Evaluation of COVID-19 Patients in Fangcang Hospital: A Case Series
Abstract
Rationale: Currently, the "gold standard" is real-time reverse transcriptase-polymerase chain reaction (RT-PCR) amplification of the viral DNA for diagnosis of COVID-19 infection. However, early reports of test performance in the Wuhan outbreak showed variable sensitivities. Therefore, the simple use of RT-PCR as a discharge standard for COVID-19 patients may be risky. Early discussions suggested that CT should be the preferred modality for the diagnosis of COVID-19. However, the use of CT for COVID-19 discharge is controversial. In the Fangcang hospital, we performed multiple nucleic acid tests and chest CT examinations in all patients. For discharged patients, we performed multiple nucleic acid tests and chest CT scans on the basis of discharge standards to minimize the incidence of false negatives in nucleic acid tests.
Patient concerns: Two 42-year-old male patients with mild to moderate COVID-19 were treated in the Fangcang Hospital According to the treatment, one patient was cured and discharged, while the other patient was sent to a higher-level hospital for further treatment.
Diagnoses: Real-time reverse transcriptase-polymerase chain reaction amplification of the viral DNA for diagnosis of COVID-19 infection.
Interventions: The patients received Chinese medicine and antiviral treatment in the Fangcang Hospital.
Outcomes: At follow-up, both patients were cured after treatment and returned to normal life after 2 weeks of home isolation and a negative nucleic acid test.
Lessons: The use of nucleic acid testing combined with chest CT examination can quickly diagnose patients with COVID-19 infection and evaluate their treatment in the Fangcang Hospital.
Keywords: COVID-19; CT; Fangcang Hospital; case report.
© 2021 Zhang et al.
Conflict of interest statement
All of the authors declare that they have no conflicts of interest for this work.
Figures
Similar articles
-
Fangcang shelter hospitals are a One Health approach for responding to the COVID-19 outbreak in Wuhan, China.One Health. 2020 Aug 29;10:100167. doi: 10.1016/j.onehlt.2020.100167. eCollection 2020 Dec. One Health. 2020. PMID: 33117879 Free PMC article.
-
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.Travel Med Infect Dis. 2020 Sep-Oct;37:101673. doi: 10.1016/j.tmaid.2020.101673. Epub 2020 Apr 18. Travel Med Infect Dis. 2020. PMID: 32311437 Free PMC article.
-
Management of COVID-19 patients in Fangcang shelter hospital: clinical practice and effectiveness analysis.Clin Respir J. 2021 Mar;15(3):280-286. doi: 10.1111/crj.13293. Epub 2020 Oct 28. Clin Respir J. 2021. PMID: 33051994 Free PMC article.
-
Thoracic imaging tests for the diagnosis of COVID-19.Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Nov 26;11:CD013639. doi: 10.1002/14651858.CD013639.pub3. PMID: 32997361 Updated.
-
Post-Hospital Discharge Strategy for COVID-19 Treatment and Control: Focus on Fangcang Hospitals.Disaster Med Public Health Prep. 2022 Oct;16(5):1795-1797. doi: 10.1017/dmp.2021.83. Epub 2021 Mar 26. Disaster Med Public Health Prep. 2022. PMID: 33766170 Free PMC article. Review.
Cited by
-
Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases.PLoS One. 2023 Nov 15;18(11):e0292783. doi: 10.1371/journal.pone.0292783. eCollection 2023. PLoS One. 2023. PMID: 37967089 Free PMC article. Clinical Trial.
-
Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients.Front Mol Biosci. 2022 Jun 28;9:865129. doi: 10.3389/fmolb.2022.865129. eCollection 2022. Front Mol Biosci. 2022. PMID: 35836936 Free PMC article.
-
Clinical Characteristics and Factors Associated with Disease Progression of Mild to Moderate COVID-19 Patients in a Makeshift (Fangcang) Hospital: A Retrospective Cohort Study.Ther Clin Risk Manag. 2021 Aug 16;17:841-850. doi: 10.2147/TCRM.S314734. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34429607 Free PMC article.
-
EDNC: Ensemble Deep Neural Network for COVID-19 Recognition.Tomography. 2022 Mar 21;8(2):869-890. doi: 10.3390/tomography8020071. Tomography. 2022. PMID: 35314648 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources